Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 54.58

-1.0%

Nov 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robohogs who wrote (6610)	6/22/2002 1:38:44 AM
From: Cary Salsberg	Read Replies (2) of 52153

I am not sure what I am wrong about. I certainly don't know about the science and the products, I have only been following this thread for 6 months, and I have NO position in biotechs, long or short, but my portfolio of "Emerging Biotechs", based on Peter's favorite 20 in December 2001, has gone from $76K to $31K (down 59%) and they seem less popular now than December. There certainly are a few major successes and profits can ONLY improve at many companies, but I see a majority of public companies that would still be venture capital supported if not for a former willingness of the market to support IPOs. Obviously, my contention that the falling prices are due to the markets increasing awareness of the perils of venture capital investing is just a hypothesis to characterize and explain what I have witnessed in the market place.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next